ad image

Gene Therapy

1 / 3
Rewriting the Rules of Gene Therapy with Nonviral DNA Delivery using dbDNA
Nonviral Delivery

Rewriting the Rules of Gene Therapy with Nonviral DNA Delivery using dbDNA

Lisa Caproni

Touchlight

PAO-12-24-CL-4Dec 16, 2024
Beacon Therapeutics
Clinical Trials

Beacon Therapeutics Announces Positive 3-Month Data from Phase 2 DAWN Trial in Patients

Beacon Therapeutics

PR-12-24-NI-131Dec 06, 2024
U.S. Food & Drug Administration
Gene Therapy

FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency

U.S. Food & Drug Administration

PR-11-24-NI-100Nov 15, 2024
Five Small Biotechs to Watch: October 2024
Biotech

Five Small Biotechs to Watch: October 2024

David Alvaro, Ph.D.

Pharma's Almanac

PR-09-24-NI-10Sep 23, 2024
Revolutionizing the Genetic Medicine Landscape with Enzymatic DNA
dbDNA

Revolutionizing the Genetic Medicine Landscape with Enzymatic DNA

Jill Makin

Touchlight

PAO-08-24-CL-01Aug 19, 2024
Genezen
Cell Therapy

Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA

Genezen

PR-07-24-NI-01Jul 02, 2024
CRB
Digitalization, AI, and Automation

Digitalization, AI, and Automation Lead Pack of Advances Fueling Life Sciences Industry Growth, New CRB Report Finds

CRB

PR-M10-23-05Oct 19, 2023
Optimizing Plasmid Production to Meet Growing Demand
Plasmid Manufacturing

Optimizing Plasmid Production to Meet Growing Demand

Cynthia A. Challener, Ph.D.; Danielle Alvarez

Pharma's Almanac

PAO-04-23-NI-01Apr 03, 2023
Expanding Patient Access to Gene Therapies through AAV Capsid Engineering
AAV Capsid Engineering

Expanding Patient Access to Gene Therapies through AAV Capsid Engineering

Damien Marsic, Ph.D.

Porton Advanced Solutions

PAO-01-23-CL-02-155Feb 06, 2023
SNIPR BIOME
CRISPR Clinical Trial

SNIPR BIOME Initiates First-in-Human Clinical Trial with SNIPR001

SNIPR BIOME

PR-M04-22-11Apr 20, 2022
Why the Big Shifts in Gene Therapy Investments? It’s Late in the Game
Column: M&A

Why the Big Shifts in Gene Therapy Investments? It’s Late in the Game

Nigel Walker

Nice Insight

PAO-03-022-NI-08Mar 23, 2022
Overcoming Analytical Challenges for Gene Therapies
Gene Therapy Analytics

Overcoming Analytical Challenges for Gene Therapies

Jennifer Chadwick, Ph.D.

ProtaGene

PAO-02-022-CL-14Mar 20, 2022
Optimizing Yields, Tech Transfer, and the Supply Chain for Viral Vector Manufacturing
Viral Vector Manufacturing

Optimizing Yields, Tech Transfer, and the Supply Chain for Viral Vector Manufacturing

Andrew Moreo; Lenore Giannunzio

Andelyn Biosciences

PAO-02-022-CL-01Mar 12, 2022
Changing Lives, One Patient at a Time
Gene Therapy

Changing Lives, One Patient at a Time

Andelyn Biosciences

PAO-01-22-R250-16Jan 31, 2022
2021 Roundup: The Year of Cell and Gene Therapy

2021 Roundup: The Year of Cell and Gene Therapy

David Alvaro, Ph.D.

Pharma's Almanac

PA734Dec 20, 2021
A Customer-Centric Approach to Cell and Gene Therapy Manufacturing
Gene Therapy

A Customer-Centric Approach to Cell and Gene Therapy Manufacturing

Drew Brennan

Avid Bioservices

PAO-10-21-CL-06Oct 13, 2021
Navigating Analytical Requirements for GMP Viral Vectors
Viral Vectors

Navigating Analytical Requirements for GMP Viral Vectors

Will Fountain

Andelyn Biosciences

PAO-10-21-CL-02Oct 08, 2021
Building a Bridge of Equivalence to Facilitate and Implement Rapid Process Changes in Gene Therapy Manufacturing
Gene Therapy

Building a Bridge of Equivalence to Facilitate and Implement Rapid Process Changes in Gene Therapy Manufacturing

Wade Macedone; Jonathan Rush; Phillip Vermilion; Samir Acharya, Ph.D.

Andelyn Biosciences

PAO-10-21-CL-01Oct 07, 2021
Pandemic Playbook for Gene Therapy Manufacturing
Gene Therapy

Pandemic Playbook for Gene Therapy Manufacturing

Ratish Krishnan; David Loong, Ph.D.; Nargisse El-Hajjami, Ph.D.

MilliporeSigma

PAO-09-21-CL-14Sep 29, 2021
Quality and Regulatory Challenges Surrounding New Cell and Gene Therapy Products
Cell and Gene Therapy

Quality and Regulatory Challenges Surrounding New Cell and Gene Therapy Products

Jennifer Cheung

WuXi Advanced Therapies

PAO-09-21-CL-07Sep 14, 2021
1 / 3